A pilot study investigating early postoperative changes of plasma polyunsaturated fatty acids after laparoscopic sleeve gastrectomy

Lipids in Health and Disease

Volumn 13, Issue 1, 2014, Pages

  Aslan, Mutay ^a   Aslan, Ibrahim ^b   Özcan, Filiz ^a   Erylmaz, Ramazan ^b   Ensari, Cemal Ozben ^b   Bilecik, Tuna ^b  

^a AKDENIZ UNIVERSITY   (Turkey)

^b Orthopaedics and Traumatology Clinic   (Turkey)

Author keywords

Insulin; Laparoscopic sleeve gastrectomy; Polyunsaturated fatty acids; Prostaglandin

Indexed keywords

ARACHIDONIC ACID; DIHOMO GAMMA LINOLENIC ACID; DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; INSULIN; PROSTAGLANDIN E2; UNSATURATED FATTY ACID;

ADULT; ARTICLE; BLOOD SAMPLING; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME IMMUNOASSAY; FATTY ACID BLOOD LEVEL; FEEDING; FEMALE; HUMAN; LAPAROSCOPIC SLEEVE GASTRECTOMY; LAPAROSCOPIC SURGERY; MALE; MONITORING; MULTIPLE REACTION MONITORING; OBESITY; PILOT STUDY; POSTOPERATIVE PERIOD; SLEEVE GASTRECTOMY; TANDEM MASS SPECTROMETRY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; WEIGHT CONTROL; BLOOD; ELECTROSPRAY MASS SPECTROMETRY; GASTRECTOMY; LAPAROSCOPY;

8,11,14-EICOSATRIENOIC ACID; ARACHIDONIC ACID; DINOPROSTONE; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; FATTY ACIDS, UNSATURATED; GASTRECTOMY; HUMANS; INSULIN; LAPAROSCOPY; OBESITY; PILOT PROJECTS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

EID: 84898549417     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-13-62     Document Type: Article

References (28)

1. Health implications of high dietary omega-6 polyunsaturated fatty acids. Patterson E, Wall R, Fitzgerald GF, Ross RP, Stanton C, J Nutr Metab 2012 2012 539426 22570770
2. Fatty acids from fish: the anti-inflammatory potential of long-chain omega-3 fatty acids. Wall R, Ross RP, Fitzgerald GF, Stanton C, Nutr Rev 2010 68 280 289 10.1111/j.1753-4887.2010.00287.x 20500789
3. Omega-3 fatty acids: new insights into the pharmacology and biology of docosahexaenoic acid, docosapentaenoic acid, and eicosapentaenoic acid. Davidson MH, Curr Opin Lipidol 2013 24 467 474 10.1097/MOL.0000000000000019 24184945
4. Low serum eicosapentaenoic acid/arachidonic acid ratio in male subjects with visceral obesity. Inoue K, Kishida K, Hirata A, Funahashi T, Shimomura I, Nutr Metab (Lond) 2013 10 25 10.1186/1743-7075-10-25 23497138
5. Relationship between acute phase proteins and serum fatty acid composition in morbidly obese patients. Fernandes R, Beserra BT, Cunha RS, Hillesheim E, Camargo Cde Q, Pequito DC, de Castro IC, Fernandes LC, Nunes EA, Trindade EB, Dis Markers 2013 35 105 112 24167354
6. Effectiveness of laparoscopic sleeve gastrectomy (first stage of biliopancreatic diversion with duodenal switch) on co-morbidities in super-obese high-risk patients. Silecchia G, Boru C, Pecchia A, Rizzello M, Casella G, Leonetti F, Basso N, Obes Surg 2006 16 1138 1144 10.1381/096089206778392275 16989696 (Pubitemid 44433149)
7. Early postoperative insulin-resistance changes after sleeve gastrectomy. Rizzello M, Abbatini F, Casella G, Alessandri G, Fantini A, Leonetti F, Basso N, Obes Surg 2010 20 50 55 10.1007/s11695-009-0017-2 19916040
8. Hormonal modulation of delta6 and delta5 desaturases: case of diabetes. Brenner RR, Prostaglandins Leukot Essent Fatty Acids 2003 68 151 162 10.1016/S0952-3278(02)00265-X 12538079 (Pubitemid 36216479)
9. Low phospholipid arachidonic acid values in diabetic platelets. Jones DB, Carter RD, Haitas B, Mann JI, Br Med J (Clin Res Ed) 1983 286 173 175 10.1136/bmj.286.6360.173 6401517
10. Polyunsaturated fatty acids in plasma and erythrocyte membrane lipids of diabetic children. Decsi T, Minda H, Hermann R, Kozári A, Erhardt E, Burus I, Molnár S, Soltész G, Prostaglandins Leukot Essent Fatty Acids 2002 67 203 210 10.1054/plef.2002.0420 12401433 (Pubitemid 35192163)
11. LC-MS/MS analysis of plasma polyunsaturated fatty acids in type 2 diabetic patients after insulin analog initiation therapy. Aslan M, Ozcan F, Aslan B, Yücel G, Lipids Health Dis 2013 12 169 10.1186/1476-511X-12-169 24195588
12. First-phase insulin secretion, insulin sensitivity, ghrelin, GLP-1, and PYY changes 72 h after sleeve gastrectomy in obese diabetic patients: the gastric hypothesis. Basso N, Capoccia D, Rizzello M, Abbatini F, Mariani P, Maglio C, Coccia F, Borgonuovo G, De Luca ML, Asprino R, Alessandri G, Casella G, Leonetti F, Surg Endosc 2011 25 3540 3550 10.1007/s00464-011-1755-5 21638183
13. Inter-disciplinary European guidelines on surgery of severe obesity. Fried M, Hainer V, Basdevant A, Buchwald H, Deitel M, Finer N, Greve JW, Horber F, Mathus-Vliegen E, Scopinaro N, Steffen R, Tsigos C, Weiner R, Widhalm K, Int J Obes (Lond) 2007 31 569 577 17325689 (Pubitemid 46482359)
14. Use and abuse of HOMA modeling. Wallace TM, Levy JC, Matthews DR, Diabetes Care 2004 27 1487 1495 10.2337/diacare.27.6.1487 15161807 (Pubitemid 38680001)
15. Analysis of very long-chain fatty acids using electrospray ionization mass spectrometry. Valianpour F, Selhorst JJ, van Lint LE, van Gennip AH, Wanders RJ, Kemp S, Mol Genet Metab 2003 79 189 196 10.1016/S1096-7192(03)00098- 2 12855224 (Pubitemid 36809046)
16. Early postoperative changes of HDL subfraction profile and HDL-associated enzymes after laparoscopic sleeve gastrectomy. Doǧan S, Aslan I, Erylmaz R, Ensari CO, Bilecik T, Aslan M, Obes Surg 2013 23 1973 1980 10.1007/s11695-013-1011-2 23760763
17. Effects of diabetes and insulin on hepatic delta6 desaturase gene expression. Rimoldi OJ, Finarelli GS, Brenner RR, Biochem Biophys Res Commun 2001 283 323 326 10.1006/bbrc.2001.4785 11327701 (Pubitemid 32924691)
18. Decreased activity of desaturase 5 in association with obesity and insulin resistance aggravates declining long-chain n-3 fatty acid status in Cree undergoing dietary transition. Zhou YE, Kubow S, Dewailly E, Julien P, Egeland GM, Br J Nutr 2009 102 888 894 10.1017/S0007114509301609 19338705
19. Comparative in vivo and in vitro study of the influence of experimental diabetes on rat liver linoleic acid delta 6- and delta 5-desaturation. Poisson JP, Enzyme 1985 34 1 14 3002783 (Pubitemid 16226910)
20. Depression of microsomal desaturation of linoleic to gamma-linolenic acid in the alloxan-diabetic rat. Mercuri O, Peluffo RO, Brenner RR, Biochim Biophys Acta 1966 116 409 411 10.1016/0005-2760(66)90028-2 5956925
21. Plasma n-3 polyunsaturated fatty acids are negatively associated with obesity. Micallef M, Munro I, Phang M, Garg M, Br J Nutr 2009 102 1370 1374 10.1017/S0007114509382173 19454127
22. The use of ω-3 poly-unsaturated fatty acids in heart failure: a preferential role in patients with diabetes. Kazemian P, Kazemi-Bajestani SM, Alherbish A, Steed J, Oudit GY, Cardiovasc Drugs Ther 2012 26 311 320 10.1007/s10557-012-6397-x 22644698
23. Obesity induced insulin resistance and hepatic steatosis are alleviated by omega-3 fatty acids: a role for resolvins and protectins. González-Périz A, Horrillo R, Ferré N, Gronert K, Dong B, Morán-Salvador E, Titos E, Martínez-Clemente M, López-Parra M, Arroyo V, Clària J, FASEB J 2009 23 1946 1957 10.1096/fj.08-125674 19211925
24. Association of serum levels of arachidonic acid and eicosapentaenoic acid with prevalence of major adverse cardiac events after acute myocardial infarction. Ueeda M, Doumei T, Takaya Y, Ohnishi N, Takaishi A, Hirohata S, Miyoshi T, Shinohata R, Usui S, Kusachi S, Heart Vessels 2011 26 145 152 10.1007/s00380-010-0038-8 20963593
25. Polyunsaturated fatty acids, inflammation, and immunity. Calder PC, Lipids 2001 36 1007 1024 10.1007/s11745-001-0812-7 11724453 (Pubitemid 33065203)
26. Differential effects of prostaglandin derived from omega-6 and omega-3 polyunsaturated fatty acids on COX-2 expression and IL-6 secretion. Bagga D, Wang L, Farias-Eisner R, Glaspy JA, Reddy ST, Proc Natl Acad Sci U S A 2003 100 1751 1756 10.1073/pnas.0334211100 12578976 (Pubitemid 36254520)
27. Essential fatty acid metabolism in patients with essential hypertension, diabetes mellitus and coronary heart disease. Das UN, Prostaglandins Leukot Essent Fatty Acids 1995 52 387 391 10.1016/0952-3278(95)90066-7 7644560
28. Arachidonic acid and lipoxin A4 as possible endogenous anti-diabetic molecules. Das UN, Prostaglandins Leukot Essent Fatty Acids 2013 88 201 210 10.1016/j.plefa.2012.11.009 23295193